Apyx Medical Corp Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Apyx Medical Corp (APYX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $4.65 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $1.42, a 39.83% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.36, a 5.60% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $2.50, a 77.19% decline year-over-year.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $1.38, a 38.94% decline from fiscal 2024.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $2.26, a 14.07% decline from fiscal 2023.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $2.63, a 75.28% decline from fiscal 2022.
- Apyx Medical Corp share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $10.64, a 13.55% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.65 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | $1.38 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $1.38 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | $1.35 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | $1.42 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | $2.26 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $2.26 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | $2.36 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $2.36 10-Q · filed 2024-05-09 | ||||
| 2023-12-31 | $2.63 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $2.63 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | $2.50 10-Q · filed 2023-08-11 | ||||
| 2023-03-31 | $2.50 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | $10.64 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $10.64 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | $10.96 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | $10.96 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | $9.37 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $9.37 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | $9.32 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | $9.29 10-Q · filed 2021-05-12 | ||||
| 2020-12-31 | $7.94 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $7.94 10-Q · filed 2020-11-09 | ||||
| 2020-06-30 | $8.18 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | $8.18 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $7.70 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $7.70 10-Q · filed 2019-11-15 | ||||
| 2019-06-30 | $7.73 10-Q · filed 2019-08-07 | ||||
| 2019-03-31 | $7.73 10-Q/A · filed 2020-05-08 | ||||
| 2018-12-31 | $2.40 10-K · filed 2020-03-31 | ||||
| 2018-09-30 | $4.08 10-Q/A · filed 2020-05-08 | ||||
| 2018-06-30 | $2.95 10-Q · filed 2018-08-01 | ||||
| 2018-03-31 | $2.53 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | $3.09 10-K · filed 2020-03-31 | ||||
| 2017-09-30 | $3.26 10-Q · filed 2017-11-03 | ||||
| 2017-06-30 | $3.32 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | $3.85 10-Q · filed 2017-05-15 | ||||
| 2016-12-31 | $1.87 10-K · filed 2019-03-14 | ||||
| 2016-09-30 | $1.76 10-Q · filed 2016-10-27 | ||||
| 2016-06-30 | $1.74 10-Q · filed 2016-08-02 | ||||
| 2016-03-31 | $1.82 10-Q · filed 2016-05-11 | ||||
| 2015-12-31 | $2.21 10-K · filed 2017-03-10 | ||||
| 2015-09-30 | $2.52 10-Q · filed 2015-11-05 | ||||
| 2015-06-30 | $3.02 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | $3.58 10-Q · filed 2015-05-08 | ||||
| 2014-12-31 | $3.88 10-K · filed 2016-03-18 | $592000.00 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $3.88 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | $3.84 10-Q · filed 2014-08-08 | ||||
| 2014-03-31 | $3.90 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $2.36 10-K · filed 2015-02-27 | ||||
| 2013-09-30 | $4.41 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $5.42 10-Q/A · filed 2013-09-25 | ||||
| 2013-03-31 | $5.42 10-Q · filed 2013-05-15 | ||||
| 2012-12-31 | $2.90 10-K/A · filed 2014-05-08 | ||||
| 2012-09-30 | $2.58 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $2.79 10-Q · filed 2012-08-14 | ||||
| 2011-12-31 | $2.81 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |